TABLE 1.
Molecular target |
Example of inhibitory drug |
|
---|---|---|
Global metastases processes | ||
Apoptosis/Anoikis | AKT | MK-2206 |
mTOR | Temsirolimus | |
Angiogenesis | VEGF | Bevacizumab |
VEGFR | Sorafenib | |
Preferential OS processes | ||
Invasion | c-SRC | Saracatinib |
Migration | HGF/c-MET | PF-02341066 |
Proliferation/survival | IGF-1R | Cixutumumab |